The vector of anti-MAGE-A3 T cell receptor (TCR) is constructed for the engineering of T cell to target Human MAGE-A3. The T cells are genetically modified through transduction with a lentiviral vector expressing MAGE-A3-specific T cell receptor. And the vector product was designed for the treatment of Melanoma, myeloma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-TCR-C252||Lenti-MAGE-A3 Murinized T cell receptor (R12C9) Viral Particle|
|TCR-C129Z||Human anti-MAGE-A3 T cell receptor (TCRVα38/Vβ2), pCDTCR1|
|TCR-L363||Murinized anti-MAGE-A3 T cell receptor (R12C9), pCDTCR1|
|VP-TCR-C242||Lenti-MAGE-A3 (EVDPIGHLY) T cell receptor (Affinity enhanced) Viral Particle|
|VP-TCR-C241||Lenti-MAGE-A3 T cell receptor (13-18) Viral Particle|
|VP-TCR-C243||Lenti-MAGE-A3 T cell receptor (6F9) Viral Particle|
|VP-TCR-C237||Lenti-MAGE-A3 T cell receptor (MAG-IC3) Viral Particle|
|VP-TCR-C240||Lenti-MAGE-A3 T cell receptor (A10) Viral Particle|
|VP-TCR-C251||Lenti-MAGE-A3 Murinized T cell receptor (6F9) Viral Particle|
|TCR-L061||Mouse anti-MAGEA3 (EVDPIGHLY) T Cell Receptor, pLXSN|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved